Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the...
The number of companies racing to find an Ebola treatment is increasing. All drugs remain in the testing stage, but that hasn't stopped...
U.S. markets fell sharply Wednesday, with the Dow Jones Industrial Average slumping 238 points and the Nasdaq shedding nearly 1.5% on...
Tekmira Pharma (Nasdaq: TKMR) stock surged more than 25% to $26.50 Wednesday after the CDC confirmed Tuesday the first Ebola...
Dow Jones today, October 1, 2014: The Dow Jones Industrial Average fell 28 points Tuesday as both domestic and global...
Stock market close, Aug. 8, 2014: The DJIA and other U.S. markets soared on Friday after positive...
Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) stock surged some 20% to $17.23 Friday after an update on its Ebola treatment.
The U.S....
Tekmira Pharmaceutical (Nasdaq: TKMR) is on a roller coaster ride as investors bet on its chances to be the first drug to successfully develop...
